시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 구강암 치료 시장 보고서(2025년)
Oral Cancer Treatment Global Market Report 2025
상품코드 : 1694684
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,260,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,049,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,837,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

구강암 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.9%의 연평균 복합 성장률(CAGR)로 28억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 혁신적인 치료법에 대한 규제 당국의 지원, 바이오마커 연구의 발전, 치료 옵션의 확대, 스크리닝 및 조기 발견의 개선, 원격 의료, 원격 모니터링 등에 기인하는 것으로 추정됩니다. 예측 기간 동안 세계 주요 동향으로는 세계 역학 변화, 규제 변경 및 승인, 인식 개선 및 조기 발견 캠페인, 환자 중심 의료, 보조 요법 등이 있습니다.

담배 소비 증가는 향후 구강암 치료 시장의 성장을 견인할 것으로 예상됩니다. 담배는 니코티아나 타바쿰 및 니코티아나 속의 다른 식물의 잎에서 얻어지지만, 유해 물질, 발암 물질, 니코틴을 함유하고 있으며, 구강암을 포함한 다양한 암의 위험 증가와 관련이 있습니다. 예를 들어, 2023년 12월 영국 정부 기관인 국립보건서비스(National Health Service)는 2022-23년 흡연과 관련된 입원 환자 수는 약 408,700명으로 2021-22년 389,800명에서 4.8% 증가했다고 보고했습니다. 따라서 담배 소비 증가가 구강암 치료 시장의 성장을 가속하고 있습니다.

구강암의 유병률 증가는 구강암 치료 시장을 이끄는 중요한 요인이 될 것으로 예상됩니다. 구강암은 구강 조직에 영향을 미치는 통제할 수 없는 세포 증식과 침윤이 특징이며, 일반적으로 수술적 절제, 방사선 치료, 화학요법으로 치료되며, 2022년 미국 암 협회는 매년 약 54,540건의 구강암 또는 구인두암이 새로 발생하여 약 11,580명이 사망할 것으로 예상하고 있습니다. 이 사망하고 있다고 보고하고 있습니다. 이에 따라 구강암 발병률 증가는 구강암 치료 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Oral cancer treatment encompasses medical interventions and therapies aimed at diagnosing, managing, and potentially curing cancer that develops in the oral cavity or oral tissues. The chosen treatment approach is contingent upon factors such as the type, stage, and location of the cancer, as well as the overall health of the patient.

The primary types of oral cancer treatment are designed for conditions such as oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. Oral squamous cell carcinoma originates in the squamous cells lining the oral cavity, including the lips, tongue, inner lining of the cheeks, and gums. Various therapeutic modalities include chemotherapy, radiation therapy, and biological therapy, administered through oral, injectable, and other routes. The diverse end users include hospitals, homecare, specialty clinics, and others.

The oral cancer treatment market research report is one of a series of new reports from The Business Research Company that provides oral cancer treatment market statistics, including oral cancer treatment industry global market size, regional shares, competitors with an oral cancer treatment market share, detailed oral cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the oral cancer treatment industry. This oral cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral cancer treatment market size has grown strongly in recent years. It will grow from $2.04 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to interdisciplinary treatment approaches, screening programs implementation, improvements in palliative care, reconstructive surgery innovations, clinical trial discoveries.

The oral cancer treatment market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to regulatory support for innovative therapies, advancements in biomarker research, expanding therapeutic options, improved screening and early detection, telemedicine and remote monitoring. Major trends in the forecast period include global epidemiological changes, regulatory changes and approvals, rising awareness and early detection campaigns, patient-centric care, adjuvant therapies.

The increasing consumption of tobacco is projected to drive the growth of the oral cancer treatment market in the future. Tobacco, derived from the leaves of Nicotiana tabacum and other plants in the Nicotiana genus, contains harmful substances, carcinogens, and nicotine, which are associated with a heightened risk of various cancers, including oral cancer. For example, in December 2023, the National Health Service, a government department in the UK, reported an estimated 408,700 hospital admissions related to smoking in the 2022-23 period, up from 389,800 in 2021-22, reflecting a rise of 4.8%. Therefore, the rising tobacco consumption is fueling the growth of the oral cancer treatment market.

The growing prevalence of oral cancer is expected to be a key factor propelling the oral cancer treatment market. Oral cancer, characterized by uncontrolled cell growth and invasion affecting oral cavity tissues, is typically treated through surgical resection, radiation therapy, and chemotherapy, depending on the disease's stage. In 2022, the American Cancer Society reported approximately 54,540 new cases of oral cavity or oropharyngeal cancer each year, leading to approximately 11,580 deaths annually. Consequently, the rising incidence of oral cancer stands as a driving force for the growth of the oral cancer treatment market.

Major companies in the oral cancer treatment market are focusing on developing innovative solutions such as CancerDetect to enhance their market profitability. CancerDetect, a screening test for mouth and throat cancer, was launched by Viome Life Sciences Inc. in August 2022. This at-home test aims to detect early-stage oral and throat cancer biomarkers, particularly oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC).

In August 2022, Merck & Co. Inc., a leading pharmaceutical company in oral cancer drug development, collaborated with Orna Therapeutics. This collaboration seeks to accelerate the development of RNA therapies, leveraging the combined expertise of both companies to provide new treatment options for patients. The partnership with Orna Therapeutics aligns with Merck & Co.'s commitment to advancing innovative cancer treatments and improving patient outcomes. Orna Therapeutics, a biotech firm in the United States, specializes in developing treatments for various illnesses, including cancer.

Major companies operating in the oral cancer treatment market report are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co., AbbVie Inc., Novartis AG, Bayer AG, Sanofi-Aventis LLC, Bristol Myers Squibb, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG., Viatris Inc., Teva Pharmaceuticals Industries Ltd., MD Anderson Cancer Center, Bausch Health Companies Inc., Memorial Sloan Kettering Cancer Center, Aurobindo Pharma Limited, Cipla Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Fred Hutchinson Cancer Research Center, Fresenius Kabi AG, Innovent Biologics Inc., Genentech Inc., Intas Pharmaceuticals Ltd., Ascendis Pharma A/S, Qilu Pharmaceutical Co. Ltd.

North America was the largest region in the oral cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oral cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oral cancer treatment market consists of revenues earned by entities by providing services such as diagnosis and staging, surgical services, radiation therapy, chemotherapy and targeted therapy, immunotherapy, and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral cancer treatment market also includes sales of biopsy tools, imaging equipment, endoscopes, surgical instruments, radiation machines, cisplatin, docetaxel, methotrexate, bleomycin sulfate, and pembrolizumab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for oral cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Oral Cancer Treatment Market Characteristics

3. Oral Cancer Treatment Market Trends And Strategies

4. Oral Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Cancer Treatment Growth Analysis And Strategic Analysis Framework

6. Oral Cancer Treatment Market Segmentation

7. Oral Cancer Treatment Market Regional And Country Analysis

8. Asia-Pacific Oral Cancer Treatment Market

9. China Oral Cancer Treatment Market

10. India Oral Cancer Treatment Market

11. Japan Oral Cancer Treatment Market

12. Australia Oral Cancer Treatment Market

13. Indonesia Oral Cancer Treatment Market

14. South Korea Oral Cancer Treatment Market

15. Western Europe Oral Cancer Treatment Market

16. UK Oral Cancer Treatment Market

17. Germany Oral Cancer Treatment Market

18. France Oral Cancer Treatment Market

19. Italy Oral Cancer Treatment Market

20. Spain Oral Cancer Treatment Market

21. Eastern Europe Oral Cancer Treatment Market

22. Russia Oral Cancer Treatment Market

23. North America Oral Cancer Treatment Market

24. USA Oral Cancer Treatment Market

25. Canada Oral Cancer Treatment Market

26. South America Oral Cancer Treatment Market

27. Brazil Oral Cancer Treatment Market

28. Middle East Oral Cancer Treatment Market

29. Africa Oral Cancer Treatment Market

30. Oral Cancer Treatment Market Competitive Landscape And Company Profiles

31. Oral Cancer Treatment Market Other Major And Innovative Companies

32. Global Oral Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Cancer Treatment Market

34. Recent Developments In The Oral Cancer Treatment Market

35. Oral Cancer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기